Suven Life Sciences net profit more than doubled at ₹36 crore in the third quarter ended December 31, 2013, compared with ₹7.8 crore in the year-ago period. Total revenue increased by 92 per cent to ₹120 crore from ₹62.8 crore. The growth in profit was due to pre-launch supplies of three products under the contract research and manufacturing services segment, the company said in a release. Suven’s scrip lost 0.89 per cent on the BSE to close at ₹78.10.